Radiology, Vol 189, 807-812, Copyright © 1993 by Radiological Society of North America

ARTICLES

Change induced by radiation therapy in FDG uptake in normal and malignant structures of the head and neck: quantitation with PET

SD Rege, L Chaiken, CK Hoh, Y Choi, R Lufkin, Y Anzai, G Juillard, J Maddahi, ME Phelps and RA Hawkins
Department of Radiological Sciences, Laboratory of Biomedical and Environmental Sciences, Los Angeles, Calif.

PURPOSE: To quantitate the changes induced in uptake of the glucose analog 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG) in normal structures in the head and neck and compare these to the change in uptake in malignant structures in patients with head and neck tumors undergoing radiation therapy. MATERIALS AND METHODS: Eleven patients with biopsy-confirmed squamous cell carcinoma of the head and neck were studied before, during, and after a 6-week course of radiation therapy with positron emission tomography (PET)-FDG imaging. A ratio of FDG uptake in the structure compared with that in the cerebellum (termed metabolic ratio) within and outside of the field of radiation was determined in the adenoids; lingual and palatine tonsils; parotid, submandibular, and sublingual glands; and nasal turbinates, soft palate, and gingiva. RESULTS: The average metabolic ratio in the tonsils, nasal turbinates, soft palate, and gingiva did not change significantly with treatment. CONCLUSION: FDG uptake in normal structures does not change with radiation therapy. This fact is in marked contrast to the FDG uptake in squamous cell carcinomas in the head and neck, which decrease dramatically with treatment (P < .005).

This article has been cited by other articles:

				M. B. Fukui, T. M. Blodgett, C. H. Snyderman, J. J. Johnson, E. N. Myers, D. W. Townsend, and C. C. Meltzer Combined PET-CT in the Head and Neck: Part 2. Diagnostic Uses and Pitfalls of Oncologic Imaging RadioGraphics, July 1, 2005; 25(4): 913 - 930. [Abstract] [Full Text] [PDF]

				Y. Kitagawa, S. Nishizawa, K. Sano, T. Ogasawara, M. Nakamura, N. Sadato, M. Yoshida, and Y. Yonekura Prospective Comparison of 18F-FDG PET with Conventional Imaging Modalities (MRI, CT, and 67Ga Scintigraphy) in Assessment of Combined Intraarterial Chemotherapy and Radiotherapy for Head and Neck Carcinoma J. Nucl. Med., February 1, 2003; 44(2): 198 - 206. [Abstract] [Full Text] [PDF]

				T. Higashi, S. J. Fisher, R. S. Brown, K. Nakada, G. L. Walter, and R. L. Wahl Evaluation of the Early Effect of Local Irradiation on Normal Rodent Bone Marrow Metabolism Using FDG: Preclinical PET Studies J. Nucl. Med., December 1, 2000; 41(12): 2026 - 2035. [Abstract] [Full Text] [PDF]

				E. Di Martino, B. Nowak, H. A. Hassan, R. Hausmann, G. Adam, U. Buell, and M. Westhofen Diagnosis and Staging of Head and Neck Cancer: A Comparison of Modern Imaging Modalities (Positron Emission Tomography, Computed Tomography, Color-Coded Duplex Sonography) With Panendoscopic and Histopathologic Findings Arch Otolaryngol Head Neck Surg, December 1, 2000; 126(12): 1457 - 1461. [Abstract] [Full Text] [PDF]

				V. J. Lowe, H. Kim, J. H. Boyd, J. F. Eisenbeis, F. R. Dunphy, and J. W. Fletcher Primary and Recurrent Early Stage Laryngeal Cancer: Preliminary Results of 2-[Fluorine 18]fluoro-2-deoxy-D-glucose PET Imaging Radiology, September 1, 1999; 212(3): 799 - 802. [Abstract] [Full Text]

				O. S. AAssar, N. J. Fischbein, G. R. Caputo, M. J. Kaplan, D. C. Price, M. I. Singer, W. P. Dillon, and R. A. Hawkins Metastatic Head and Neck Cancer: Role and Usefulness of FDG PET in Locating Occult Primary Tumors Radiology, January 1, 1999; 210(1): 177 - 181. [Abstract] [Full Text]